FBDIX holdings — Franklin Biotechnology Discovery Fund
Franklin Biotechnology Discovery Fund (FBDIX) held 126 positions with net assets of $1.15B as of July 31, 2026, according to its Form N-PORT report to the SEC. Its top 10 holdings make up 36.3% of the fund, led by Jazz Pharmaceuticals plc, AMGN, GILD.
FBDIX top holdings
- Jazz Pharmaceuticals plc — 5.66% ($65.3M)
- AMGN Amgen, Inc. — 4.39% ($50.7M)
- GILD Gilead Sciences, Inc. — 3.86% ($44.5M)
- REGN Regeneron Pharmaceuticals, Inc. — 3.77% ($43.5M)
- ARGX Argenx SE — 3.62% ($41.8M)
- VRTX Vertex Pharmaceuticals, Inc. — 3.54% ($40.8M)
- Franklin Institutional U.S. Government Money Market Fund — 3.18% ($36.7M)
- RVMD Revolution Medicines, Inc. — 3.01% ($34.8M)
- GH Guardant Health, Inc. — 2.76% ($31.8M)
- Ascendis Pharma A/S — 2.56% ($29.6M)
- DNTH Dianthus Therapeutics, Inc. — 2.32% ($26.8M)
- INSM Insmed, Inc. — 1.99% ($23.0M)
- MIRM Mirum Pharmaceuticals, Inc. — 1.98% ($22.8M)
- PRAX Praxis Precision Medicines, Inc. — 1.91% ($22.1M)
- SYRE Spyre Therapeutics, Inc. — 1.87% ($21.6M)
- ORKA Oruka Therapeutics, Inc. — 1.86% ($21.5M)
- NBIX Neurocrine Biosciences, Inc. — 1.82% ($21.0M)
- BBIO Bridgebio Pharma, Inc. — 1.67% ($19.3M)
- PTCT PTC Therapeutics, Inc. — 1.65% ($19.0M)
- AstraZeneca plc — 1.51% ($17.4M)
- Franklin Institutional U.S. Government Money Market Fund — 1.45% ($16.7M)
- AMLX Amylyx Pharmaceuticals, Inc. — 1.32% ($15.3M)
- LLY Eli Lilly & Co. — 1.31% ($15.1M)
- CYTK Cytokinetics, Inc. — 1.24% ($14.3M)
- TNGX Tango Therapeutics, Inc. — 1.23% ($14.2M)
What are FBDIX's top 10 holdings?
Jazz Pharmaceuticals plc (5.7%), AMGN (4.4%), GILD (3.9%), REGN (3.8%), ARGX (3.6%), VRTX (3.5%), Franklin Institutional U.S. Government Money Market Fund (3.2%), RVMD (3.0%), GH (2.8%), Ascendis Pharma A/S (2.6%).
How many stocks are in FBDIX?
Franklin Biotechnology Discovery Fund reported 126 holdings as of July 31, 2026.
Share classes: FBDIX, FBTDX, FRBRX, FTDZX